Huadong Medicine Co. Ltd. held its Annual General Meeting of 2023 on 08 May 2024, during which the shareholders approved cash dividend/10 shares (tax included): CNY 5.80000000 for the year 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.21 CNY | -0.77% | +2.81% | -22.31% |
01:00am | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
01:00am | Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.31% | 7.78B | |
+25.19% | 75.34B | |
-2.82% | 23.86B | |
+8.31% | 8.61B | |
+10.64% | 8.52B | |
+11.90% | 5.18B | |
+1.86% | 4.13B | |
-5.04% | 4.03B | |
+3.71% | 3.82B | |
+21.59% | 3.62B |
- Stock Market
- Equities
- 000963 Stock
- News Huadong Medicine Co., Ltd
- Huadong Medicine Co., Ltd Approves Cash Dividend for the Year 2023